Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Aptorum Group Ltd Cl A (NQ: APM )

4.780 -0.480 (-9.13%)
Streaming Delayed Price Updated: 10:51 AM EDT, May 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aptorum Group Ltd Cl A

< Previous 1 2 3 4 5 6 7 Next >
Aptorum Group Announces Positive Interim Phase I Clinical Trial Progress for ALS-4 Targeting Staphylococcus aureus and Positive Pre-IND Progress for SACT-1 Targeting Neuroblastoma
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited to Present at The Benzinga Global Small Cap Conference
From Aptorum Group Limited
Via Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Conformis (NASDAQ:CFMS) stock moved upwards by 29.53% to $1.09 during Monday's pre-market session. The company's market cap stands at $198.8 million. As... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Stealth BioTherapeutics (NASDAQ:MITO) stock moved upwards by 58.33% to $1.9 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
Aptorum Group Enters into an Agreement with Exeltis to Develop Aptorum’s Novel Preclinical Candidate Targeting Woman’s Gynecological Conditions
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Interview to Air on Bloomberg Television U.S. on the RedChip Money Report
From Aptorum Group Limited
Via Business Wire
Aptorum Shares Are Trading Higher On Immunomodulators Agreement For Autoimmune, Oncology Indications
Aptorum Group Ltd (NASDAQ: APM) has entered into a material transfer and option agreement with Yale University to evaluate a group of preclinical stage novel... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Renalytix AI (NASDAQ:RNLX) stock moved upwards by 20.93% to $30.5 during Thursday's pre-market session. The market value of their outstanding shares is at $1.0... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Aptorum Group Enters Into Material Transfer and Exclusive Option-To-License Agreement with Yale University for Its Novel Immunomodulators Potentially Targeting Autoimmune and Oncology Diseases
From Aptorum Group Limited
Via Business Wire
Aptorum Group Limited Reports 2020 Fiscal Year End Financial Results and Provides Business Update
From Aptorum Group Limited
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.